TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 8512099

Group type: EXPERIMENTAL
Intervention: Intramuscular dexmedetomidine (2.5 micrograms/kg) administered 60 min before induction (DEXPLA group, n = 64)
Number of subjects: 192

Group type: EXPERIMENTAL
Intervention: Intramuscular dexmedetomidine (2.5 micrograms/kg) and intravenous fentanyl (1.5 micrograms/kg) (DEXFENT group, n = 64)
Number of subjects: 192

Group type: COMPARATOR
Intervention: Intramuscular midazolam (0.08 mg/kg) and intravenous fentanyl (1.5 micrograms/kg) (MIDFENT group, n = 64)
Number of subjects: 192

Group type: COMPARATOR
Intervention: Control group (no dexmedetomidine)
Number of subjects: 192

Group type: EXPERIMENTAL
Intervention: DEXPLA and DEXFENT groups (dexmedetomidine patients)
Number of subjects: 192
Study: 3582167

Group type: EXPERIMENTAL
Intervention: DIS
Number of subjects: 0

Group type: COMPARATOR
Intervention: SADS-L
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: DIS and SADS-L
Number of subjects: 0
Study: 29374672

Group type: EXPERIMENTAL
Intervention: rfMDA (presumptive treatment with artemether-lumefantrine)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: RACD (rapid diagnostic testing and treatment using artemether-lumefantrine)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: RAVC (IRS with Acellic 300CS)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: rfMDA+RAVC
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: RACD+RAVC
Number of subjects: 56

Group type: COMPARATOR
Intervention: No RAVC
Number of subjects: 56
Study: 26419766

Group type: EXPERIMENTAL
Intervention: Theatre-based intervention
Number of subjects: 30
Study: 25232074

Group type: EXPERIMENTAL
Intervention: Primary tendon repair
Number of subjects: 103

Group type: COMPARATOR
Intervention: Physiotherapy
Number of subjects: 103
Study: 22781525

Group type: EXPERIMENTAL
Intervention: Ultrasound guidance for ilioinguinal or iliohypogastric nerve block with 0.8% lidocaine and 0.25% levobupivacaine at 0.2 ml/kg (Group U)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Traditional method of anatomical localization with 0.3 ml/kg of the same local anesthetic (Group T)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Ultrasound guidance (Group U)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Traditional method (Group T)
Number of subjects: 100
Study: 20064249

Group type: EXPERIMENTAL
Intervention: Diclofenac sodium 1% gel (2 g applied to each hand 4 times daily for 8 weeks)
Number of subjects: 783

Group type: COMPARATOR
Intervention: Placebo gel (vehicle)
Number of subjects: 783
Study: 18669967

Group type: EXPERIMENTAL
Intervention: Eprex (pre‐operative injections of epoetin)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Bellovac (post‐operative retransfusion of shed blood)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Eprex in total hip replacement
Number of subjects: 100

Group type: COMPARATOR
Intervention: Bellovac in total hip replacement
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Eprex in total knee replacement
Number of subjects: 100

Group type: COMPARATOR
Intervention: Bellovac in total knee replacement
Number of subjects: 100
Study: 15753747

Group type: EXPERIMENTAL
Intervention: Hypertonic saline dextran (HSD) 250 mL
Number of subjects: 28

Group type: COMPARATOR
Intervention: Conventional fluid regimen with hydroxyethyl starch in normal saline solution (H-NS) 250 mL
Number of subjects: 28
Study: 12704010

Group type: EXPERIMENTAL
Intervention: Internet intervention (Web site plus 12 weekly e‐mail tip sheets)
Number of subjects: 65

Group type: COMPARATOR
Intervention: Waiting list control group
Number of subjects: 65
Study: 12670369

Group type: EXPERIMENTAL
Intervention: IGIV-C, 10% (Gamunex, 10%)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: IGIV-C, 5%
Number of subjects: 38

Group type: COMPARATOR
Intervention: IGIV-SD, 10% (Gamimune N, 10%)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: IGIV-C, 10%
Number of subjects: 38
Study: 9814858

Group type: EXPERIMENTAL
Intervention: Protease inhibitors
Number of subjects: 67

Group type: COMPARATOR
Intervention: Therapy-naive patients
Number of subjects: 67

Group type: COMPARATOR
Intervention: HIV-negative control subjects
Number of subjects: 67
Study: 7735716

Group type: EXPERIMENTAL
Intervention: Nicotinic acid
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Estrogens
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Dietary and pharmacologic agents
Number of subjects: 0
Study: 2663975

Group type: EXPERIMENTAL
Intervention: Fluoxetine
Number of subjects: 198

Group type: EXPERIMENTAL
Intervention: Imipramine
Number of subjects: 198

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 198
Study: 62998

Group type: EXPERIMENTAL
Intervention: Dapsone 5 mg daily
Number of subjects: 68

Group type: COMPARATOR
Intervention: Dapsone 50 mg daily
Number of subjects: 68
Study: 28816833

Group type: EXPERIMENTAL
Intervention: Erythromycin (25 mg/kg before and after surgery)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control (no erythromycin)
Number of subjects: 40
Study: 25615892

Group type: EXPERIMENTAL
Intervention: Voice rehabilitation
Number of subjects: 74

Group type: COMPARATOR
Intervention: Control group (no voice rehabilitation)
Number of subjects: 74
Study: 23500267

Group type: EXPERIMENTAL
Intervention: Catheter ablation
Number of subjects: 52

Group type: COMPARATOR
Intervention: Rate control
Number of subjects: 52
Study: 21803341

Group type: EXPERIMENTAL
Intervention: Using the mirror box to see the mirror reflection of the non-dominant hand during fatigue-inducing tasks
Number of subjects: 8

Group type: COMPARATOR
Intervention: Without using the mirror box during fatigue-inducing tasks
Number of subjects: 8
Study: 19780000

Group type: EXPERIMENTAL
Intervention: Thiocolchicoside ointment applied onto the trigger points
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: 8 mg thiocolchicoside intramuscular injection to the trigger points
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Both thiocolchicoside ointment and intramuscular injection
Number of subjects: 65
Study: 16442479

Group type: EXPERIMENTAL
Intervention: Symptom Monitor (intervention group, n = 69)
Number of subjects: 146

Group type: COMPARATOR
Intervention: Control group (n = 77)
Number of subjects: 146
Study: 15298946

Group type: EXPERIMENTAL
Intervention: Serum lutein
Number of subjects: 302

Group type: EXPERIMENTAL
Intervention: Serum zeaxanthin
Number of subjects: 302

Group type: EXPERIMENTAL
Intervention: Serum beta-cryptoxanthin
Number of subjects: 302

Group type: EXPERIMENTAL
Intervention: Serum levels of alpha-carotene, beta-carotene, lycopene, and alpha-tocopherol
Number of subjects: 302
Study: 11735185

Group type: EXPERIMENTAL
Intervention: Aspirin (150 mg) and below-knee compression stockings (Class 1 profile)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Control group (no aspirin or stockings)
Number of subjects: 39
Study: 9032211

Group type: EXPERIMENTAL
Intervention: PGHS‐1 immunoreactivity
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: PGHS‐2 immunoreactivity
Number of subjects: 41

Group type: COMPARATOR
Intervention: Comparison between patient populations
Number of subjects: 41

Group type: COMPARATOR
Intervention: Correlation with clinical parameters
Number of subjects: 41
Study: 8315162

Group type: EXPERIMENTAL
Intervention: SHAPEDOWN program (family‐based, multidisciplinary, behavior‐modification program)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: SHAPEDOWN program
Number of subjects: 20

Group type: COMPARATOR
Intervention: Standard treatment (standard nutrition care for subjects with IDDM)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Standard treatment
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Combined groups
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: SHAPEDOWN program and Standard treatment
Number of subjects: 20
Study: 3830242

Group type: EXPERIMENTAL
Intervention: Felodipine 10 mg b.d.
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Metoprolol 100 mg b.d.
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Combination of felodipine and metoprolol
Number of subjects: 8
Study: 31233893

Group type: EXPERIMENTAL
Intervention: Directed standing posture
Number of subjects: 60

Group type: COMPARATOR
Intervention: Natural, relaxed standing posture
Number of subjects: 60
Study: 28983060

Group type: EXPERIMENTAL
Intervention: Dexamethasone during induction
Number of subjects: 319

Group type: COMPARATOR
Intervention: Prednisone during induction
Number of subjects: 319
Study: 25925729

Group type: EXPERIMENTAL
Intervention: Topical metronidazole treatment
Number of subjects: 47

Group type: COMPARATOR
Intervention: Conventional treatment (Control)
Number of subjects: 47
Study: 23262116

Group type: EXPERIMENTAL
Intervention: Internet-based attention training (AT) using a modified dot probe paradigm
Number of subjects: 56

Group type: COMPARATOR
Intervention: Control condition without attention modification
Number of subjects: 56
Study: 22057073

Group type: EXPERIMENTAL
Intervention: Clonazepam (5 mg to 10 mg)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Zolpidem (1 mg)
Number of subjects: 23
Study: 19439813

Group type: EXPERIMENTAL
Intervention: Fluconazole
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Lacidofil
Number of subjects: 0

Group type: COMPARATOR
Intervention: Candida infection
Number of subjects: 0
Study: 17881967

Group type: EXPERIMENTAL
Intervention: Microendoscopic discectomy (MED)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Open discectomy (OD)
Number of subjects: 40
Study: 15501757

Group type: EXPERIMENTAL
Intervention: 3D7 form of MSP2
Number of subjects: 120
Study: 11915778

Group type: EXPERIMENTAL
Intervention: High-carbohydrate diet (CD; 9-10 g carbohydrate/kg lean body mass)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Habitual diet (HD; 6-7 g carbohydrate/kg lean body mass)
Number of subjects: 6
Study: 9931793

Group type: EXPERIMENTAL
Intervention: Intermittent subglottic lavage (SL)
Number of subjects: 100
Study: 8056728

Group type: EXPERIMENTAL
Intervention: Clozapine (mean sixth week daily dose 370 mg)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Haloperidol (systematic 6-week trial)
Number of subjects: 11
Study: 3051871

Group type: EXPERIMENTAL
Intervention: Multispatula
Number of subjects: 158

Group type: COMPARATOR
Intervention: Ayres Spatula
Number of subjects: 158
Study: 31809216

Group type: COMPARATOR
Intervention: AR19 20 mg
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: AR19 5 mg
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: AR19 20 mg (intact capsule with meal)
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: AR19 20 mg (fasted)
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: AR19 30 mg
Number of subjects: 96
Study: 30475851

Group type: EXPERIMENTAL
Intervention: Cash transfers (CTs) provided to adolescent girls and young women (AGYW)
Number of subjects: 32
Study: 28691360

Group type: EXPERIMENTAL
Intervention: 10% lidocaine spray applied to the ectocervix
Number of subjects: 200

Group type: COMPARATOR
Intervention: No anesthesia (control group)
Number of subjects: 200
Study: 25074639

Group type: EXPERIMENTAL
Intervention: tolcapone
Number of subjects: 66

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 66
Study: 23474344

Group type: EXPERIMENTAL
Intervention: Survivorship Care Plans (SCPs) provided during follow-up visits by physicians (n=64).
Number of subjects: 121

Group type: COMPARATOR
Intervention: No Survivorship Care Plans (no-SCP condition, n=57).
Number of subjects: 121
Study: 21427151

Group type: EXPERIMENTAL
Intervention: 20-minute mental practice
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: 40-minute mental practice
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: 60-minute mental practice
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Mental practice (all durations)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Control group (sham intervention)
Number of subjects: 29
Study: 18799992

Group type: EXPERIMENTAL
Intervention: Balance training program (4 weeks, supervised, emphasizing dynamic stabilization in single-limb stance)
Number of subjects: 31
Study: 16562643

Group type: EXPERIMENTAL
Intervention: Ciprofibrat 100 mg
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 12676060

Group type: EXPERIMENTAL
Intervention: High-functioning individuals with autism
Number of subjects: 24

Group type: COMPARATOR
Intervention: Normally developing individuals
Number of subjects: 24
Study: 10932485

Group type: EXPERIMENTAL
Intervention: THAI version of Aachen aphasia test (THAI-AAT)
Number of subjects: 125
Study: 8826768

Group type: EXPERIMENTAL
Intervention: MediHeat adult heating pad (MH-AHP)
Number of subjects: 77
Study: 1575555

Group type: EXPERIMENTAL
Intervention: Prone position
Number of subjects: 14

Group type: COMPARATOR
Intervention: Supine position
Number of subjects: 14
Study: 4059666

Group type: EXPERIMENTAL
Intervention: Inhaled beclomethasone dipropionate (BDP) 100 micrograms qds
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 31092191

Group type: EXPERIMENTAL
Intervention: Video laryngoscope
Number of subjects: 360

Group type: COMPARATOR
Intervention: Direct laryngoscope
Number of subjects: 360
Study: 28847207

Group type: EXPERIMENTAL
Intervention: Multidisciplinary health assessment (n = 83)
Number of subjects: 244

Group type: COMPARATOR
Intervention: Usual case management (Control group, n = 99)
Number of subjects: 244
Study: 26995776

Group type: EXPERIMENTAL
Intervention: OKCKE resistance training at high loads (20 sets of 2RM)
Number of subjects: 26

Group type: COMPARATOR
Intervention: OKCKE resistance training at low loads (2 sets of 20RM)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Isokinetic OKCKE resistance training at 2 sets of 20RM
Number of subjects: 26
Study: 25039590

Group type: EXPERIMENTAL
Intervention: 100-μs interphase interval (IPI) with one electrode over the common peroneal nerve
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: IPI greater than 100μs with one electrode over the common peroneal nerve
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Any IPI with both electrodes over the dorsiflexor muscles
Number of subjects: 12
Study: 22166561

Group type: EXPERIMENTAL
Intervention: Triple therapy (peginterferon alfa-2a 180 µg/week + ribavirin 1,000/1,200 mg/day + amantadine 200 mg/day)
Number of subjects: 92

Group type: COMPARATOR
Intervention: Standard of care (peginterferon alfa-2a 40KD + ribavirin)
Number of subjects: 92
Study: 20969664

Group type: EXPERIMENTAL
Intervention: Hyaluronic acid filler injections
Number of subjects: 22
Study: 17377646

Group type: EXPERIMENTAL
Intervention: Pharmaceutical industry sponsorship
Number of subjects: 229

Group type: COMPARATOR
Intervention: University sponsorship
Number of subjects: 229
Study: 15073397

Group type: EXPERIMENTAL
Intervention: Warfarin
Number of subjects: 630

Group type: COMPARATOR
Intervention: Aspirin
Number of subjects: 630
Study: 11219760

Group type: EXPERIMENTAL
Intervention: Sitting (static posture)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Sitting (dynamic multiple posture approach)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Standing
Number of subjects: 8
Study: 9041968

Group type: EXPERIMENTAL
Intervention: Intrapleural streptokinase (SK), 250,000 U in saline solution, mean duration 5.3 days
Number of subjects: 52

Group type: COMPARATOR
Intervention: Closed chest tube drainage (Drain) only
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Intrapleural streptokinase (SK)
Number of subjects: 52
Study: 7970934

Group type: EXPERIMENTAL
Intervention: Macrobioitic diet infants
Number of subjects: 41
Study: 3296288

Group type: EXPERIMENTAL
Intervention: Nifedipine (30-80 mg)
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Verapamil (120-360 mg)
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Phendilin (150-300 mg)
Number of subjects: 61
Study: 29870868

Group type: EXPERIMENTAL
Intervention: Point‐of‐Care (POC)
Number of subjects: 226

Group type: COMPARATOR
Intervention: POC plus Population Management (POC + PM)
Number of subjects: 226
Study: 27260323

Group type: EXPERIMENTAL
Intervention: 3-month pelvic floor muscle training (PFMT) program delivered via the Internet or a brochure
Number of subjects: 169

Group type: EXPERIMENTAL
Intervention: 3-month pelvic floor muscle training (PFMT) program
Number of subjects: 169

Group type: EXPERIMENTAL
Intervention: Regular PFMT at 1 year
Number of subjects: 169

Group type: EXPERIMENTAL
Intervention: Increasing age
Number of subjects: 169
Study: 24721970

Group type: EXPERIMENTAL
Intervention: Metabolomic profiling using high‐performance liquid chromatography‐quadrupole time‐of‐flight mass spectrometry (HPLC‐QTOFMS)
Number of subjects: 138

Group type: EXPERIMENTAL
Intervention: Metabolomic profiling
Number of subjects: 138
Study: 23455663

Group type: EXPERIMENTAL
Intervention: Sensorimotor training (2 sessions per week, 30-50 min each session)
Number of subjects: 102

Group type: COMPARATOR
Intervention: Control group (clinical drug treatment with Methotrexate, Leflunomide and/or Prednisone)
Number of subjects: 102
Study: 20520603

Group type: EXPERIMENTAL
Intervention: 1 g of ephedra dry extract
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: 2 g of ephedra dry extract
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 18799032

Group type: EXPERIMENTAL
Intervention: Concurrent chemoradiotherapy (RT+BP, RT+TP, RT+FP)
Number of subjects: 285

Group type: COMPARATOR
Intervention: Radiotherapy alone
Number of subjects: 285

Group type: EXPERIMENTAL
Intervention: RT+BP, RT+TP, RT+FP
Number of subjects: 285
Study: 16651305

Group type: EXPERIMENTAL
Intervention: Dichloroacetate (DCA) at a dose of 12.5 mg/kg every 12 hours for 6 months
Number of subjects: 43

Group type: COMPARATOR
Intervention: Placebo for 6 months
Number of subjects: 43
Study: 12792354

Group type: EXPERIMENTAL
Intervention: Prednisone (40 mg once daily for 14 days)
Number of subjects: 138

Group type: COMPARATOR
Intervention: Nevirapine alone
Number of subjects: 138

Group type: EXPERIMENTAL
Intervention: Treatment-naive patients
Number of subjects: 138
Study: 10981801

Group type: EXPERIMENTAL
Intervention: Nicardipine hydrochloride
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 3-isobutyl-1-methylxanthine
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Pilocarpine hydrochloride
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Nicardipine in an aqueous gel vehicle
Number of subjects: 12
Study: 9369812

Group type: EXPERIMENTAL
Intervention: No weaning of magnesium sulfate after successful tocolysis
Number of subjects: 141

Group type: COMPARATOR
Intervention: Gradual weaning of magnesium sulfate (approximately 1 gm every 4 hours)
Number of subjects: 141
Study: 1582603

Group type: COMPARATOR
Intervention: Glucose based ORS and no food for the first 24 hours (group A)
Number of subjects: 182

Group type: EXPERIMENTAL
Intervention: Glucose based ORS plus food from the beginning of treatment (group B)
Number of subjects: 182

Group type: COMPARATOR
Intervention: Rice based ORS with no food for the first 24 hours (group C)
Number of subjects: 182

Group type: EXPERIMENTAL
Intervention: Rice based ORS plus food from start of therapy (group D)
Number of subjects: 182

Group type: EXPERIMENTAL
Intervention: Rice based ORS (groups C and D)
Number of subjects: 182

Group type: COMPARATOR
Intervention: Glucose based ORS (groups A and B)
Number of subjects: 182
Study: 6375979

Group type: EXPERIMENTAL
Intervention: Fluorometholone acetate ophthalmic suspension
Number of subjects: 17

Group type: COMPARATOR
Intervention: Dexamethasone sodium phosphate ophthalmic solution
Number of subjects: 17
Study: 30059750

Group type: EXPERIMENTAL
Intervention: Adaptive servo-ventilation (ASV) with optimal medical therapy (OMT)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Optimal medical therapy (OMT)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Adaptive servo-ventilation (ASV)
Number of subjects: 35
Study: 30087298

Group type: EXPERIMENTAL
Intervention: Provision of menstrual items to schoolgirls by nurses
Number of subjects: 30
Study: 27849235

Group type: EXPERIMENTAL
Intervention: nIPPV
Number of subjects: 72

Group type: COMPARATOR
Intervention: nCPAP
Number of subjects: 72
Study: 25441855

Group type: EXPERIMENTAL
Intervention: Osteotomy without fixation and elastic bandage
Number of subjects: 100

Group type: COMPARATOR
Intervention: Osteotomy with fixation and soft cast
Number of subjects: 100

Group type: COMPARATOR
Intervention: Osteotomy with fixation and elastic bandage
Number of subjects: 100

Group type: COMPARATOR
Intervention: Osteotomy without fixation and soft cast
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Postoperative treatment with elastic bandage
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Preoperative hallux valgus angle exceeding 30°
Number of subjects: 100
Study: 22548907

Group type: EXPERIMENTAL
Intervention: Total Laparoscopic Hysterectomy (TLH)
Number of subjects: 760

Group type: COMPARATOR
Intervention: Total Abdominal Hysterectomy (TAH)
Number of subjects: 760
Study: 20613658

Group type: EXPERIMENTAL
Intervention: TRICARE's asthma disease management program
Number of subjects: 57489

Group type: EXPERIMENTAL
Intervention: TRICARE's congestive heart failure disease management program
Number of subjects: 57489

Group type: EXPERIMENTAL
Intervention: TRICARE's diabetes disease management program
Number of subjects: 57489

Group type: COMPARATOR
Intervention: Historical control group (n = 39,217)
Number of subjects: 57489
Study: 18583576

Group type: EXPERIMENTAL
Intervention: Montelukast 4 mg/day
Number of subjects: 979

Group type: EXPERIMENTAL
Intervention: Montelukast 8 mg/day
Number of subjects: 979

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 979
Study: 16491931

Group type: EXPERIMENTAL
Intervention: Pictures rated as very arousing during classical eyeblink conditioning
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Background tasks of varying complexity during conditioning
Number of subjects: 0
Study: 12047489

Group type: EXPERIMENTAL
Intervention: Monosodium (L)-glutamate (10 g)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 9952072

Group type: EXPERIMENTAL
Intervention: Panamesine (PAN) 90 mg/day
Number of subjects: 10

Group type: COMPARATOR
Intervention: Panamesine (PAN) 30 mg
Number of subjects: 10

Group type: COMPARATOR
Intervention: Clozapine
Number of subjects: 10

Group type: COMPARATOR
Intervention: Haloperidol
Number of subjects: 10
Study: 7558532

Group type: EXPERIMENTAL
Intervention: Exercise training (60 minutes of supervised weight training and aerobic activity three times each week for eight weeks)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Nonexercise group
Number of subjects: 16
Study: 2160354

Group type: EXPERIMENTAL
Intervention: Lithium carbonate (750 mg)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8